跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 97 条关于
“hedgehog”
全部
97
临床试验
60
药物
10
机构
0
资讯
27
去年
Cemiplimab Shows Promise in Advanced Basal Cell Carcinoma After Hedgehog Inhibitor Failure
9个月前
Sol-Gel Discontinues SGT-210 Development for Darier Disease After Phase 1b Trial Fails to Show Efficacy
去年
Basal Cell Neoplasm Drug Pipeline Expands with 22+ Companies Developing Novel Therapies
去年
Endeavor BioMedicines Receives Dual Orphan Drug Designation for Taladegib in Idiopathic Pulmonary Fibrosis
5个月前
Medicus Pharma Seeks Orphan Drug Designation for SkinJect in Rare Gorlin Syndrome
2年前
Advancements in Neuroplastogens, KRAS G12C Inhibitors, and Other Therapies Highlighted by Recent Deals and Clinical Readouts
去年
Sol-Gel and Mayne Pharma Announce $16 Million Deal for EPSOLAY and TWYNEO Rights in the U.S.
去年
Basal Cell Carcinoma Market Set to Reach $9.7 Billion by 2035, Driven by Early Detection and Novel Therapies
5个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
9天前
Brainomix AI Imaging Detects Significant Antifibrotic Effects of Taladegib in Phase 2a IPF Trial
第 1 页,共 3 页
上一页
下一页